Aprepitant Intravenous and Insulin Glargine (U-100) Vials
Determining the interaction of Aprepitant Intravenous and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Intravenous-Insulin Glargine (U-300) Pens
- Aprepitant Intravenous-Insulin glargine and lixisenatide
- Aprepitant Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Aprepitant Intravenous-Insulin glargine, recombinant Subcutaneous
- Aprepitant Intravenous-Insulin glulisine
- Aprepitant Intravenous-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Aprepitant Oral Suspension
- Insulin Glargine (U-100) Vials-Aprepitant/Fosaprepitant Dimeglumine
- Insulin Glargine (U-100) Vials-Apresazide
- Insulin Glargine (U-100) Vials-Apresoline
- Insulin Glargine (U-100) Vials-Apresoline Injection
- Insulin Glargine (U-100) Vials-Apri